Canada markets closed

SAB Biotherapeutics, Inc. (SABS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.0900+0.1500 (+3.81%)
At close: 04:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts2231
Avg. Estimate-0.96-1.03-3.04-6.21
Low Estimate-0.98-1.14-4.9-6.21
High Estimate-0.94-0.92-0.5-6.21
Year Ago EPS-1.5-1.4-7.64-3.04
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts2221
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago Sales581k86k2.24MN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History2023-03-302023-06-292023-09-292023-12-30
EPS Est.-0.8-1.45-1.17-0.62
EPS Actual-1.5-1.4-1-3.38
Difference-0.70.050.17-2.76
Surprise %-87.50%3.40%14.50%-445.20%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.96-1.03-3.04-6.21
7 Days Ago-0.96-1.03-3.04-6.21
30 Days Ago-0.74-0.82-3.5-6.21
60 Days Ago-0.46-0.46-1.94-1.94
90 Days Ago-0.46-0.46-1.94-1.94
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesSABSIndustrySector(s)S&P 500
Current Qtr.36.00%N/AN/AN/A
Next Qtr.26.40%N/AN/AN/A
Current Year60.20%N/AN/AN/A
Next Year-104.30%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A